These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6623652)

  • 1. Tube leukocyte adherence-inhibition response to related and unrelated tumor antigens in mammary tumor-bearing mice.
    Chattopadhyay U; Guha S
    Tumori; 1983 Aug; 69(4):299-303. PubMed ID: 6623652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The early detection of host immune response to spontaneous mouse mammary tumors by leukocyte adherence inhibition.
    Myers WL; Reynolds HA
    Immunol Lett; 1983; 7(1):1-5. PubMed ID: 6642564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of tumor-associated immunity with a leukocyte adherence inhibition (LAI) assay.
    Hellström I; Hellström KE; Shantz G
    Int J Cancer; 1976 Sep; 18(3):354-61. PubMed ID: 955746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular immunity to the mammary tumour virus in mice bearing primary mammary tumours.
    Creemers P; Bentvelzen P
    Eur J Cancer (1965); 1977 Jun; 13(6):503-10. PubMed ID: 69543
    [No Abstract]   [Full Text] [Related]  

  • 5. Leukocyte adherence inhibition as measured by a radioisotopic technique for detection of cell-mediated tumor immunity.
    Pierce GE; DeVald BL
    Int J Cancer; 1974 Dec; 14(6):833-9. PubMed ID: 4377009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Presence of C-particle group-specific antigens in the liquid phase of mouse ascitic tumors].
    Ribacchi R
    Lav Ist Anat Istol Patol Univ Studi Perugia; 1971; 31(3):91-102. PubMed ID: 4338719
    [No Abstract]   [Full Text] [Related]  

  • 7. A radio (111In) capillary tube leukocyte adherence inhibition assay for the detection of specific tumor-associated immunity.
    Peng R; Myers WL
    Immunol Commun; 1984; 13(4):293-303. PubMed ID: 6384031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantability and antigenicity of two sublines of the TA3 tumor.
    Sanford BH; Codington JF; Jeanloz RW; Palmer PD
    J Immunol; 1973 May; 110(5):1233-7. PubMed ID: 4572632
    [No Abstract]   [Full Text] [Related]  

  • 9. Leukocyte adherence inhibition (LAI) in rats bearing transplantable syngeneic tumors of different immunogenicity.
    Tank B; Marquet RL; Vennemans E; Westbroek DL
    Eur J Cancer Clin Oncol; 1985 Dec; 21(12):1539-46. PubMed ID: 3913605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation or inhibition of immune resistance against metastatic or local growth of a C3H mammary carcinoma.
    Vaage J; Agarwal S
    Cancer Res; 1976 May; 36(5):1831-6. PubMed ID: 1268839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of cell line-specific transplantation antigens from mouse ascites tumor cells.
    Tanino T; Saito M; Egawa K
    Gan; 1982 Apr; 73(2):299-307. PubMed ID: 7117755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine malignant cells synthesize a 19,000-dalton protein that is physicochemically and antigenically related to the immunosuppressive retroviral protein, P15E.
    Cianciolo GJ; Lostrom ME; Tam M; Snyderman R
    J Exp Med; 1983 Sep; 158(3):885-900. PubMed ID: 6193238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunogenic activity of tumor antigens retained by the reticuloendothelial cells of tumor-bearing mice.
    Vaage J
    Cancer Res; 1972 May; 32(5):898-903. PubMed ID: 5017740
    [No Abstract]   [Full Text] [Related]  

  • 14. [Localized irradiation on tumors and immune cell reactions--histoenzymatic evaluation using MM 46 tumor and Ehrlich tumor-bearing C3H/He mice].
    Imanaka K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Feb; 43(2):355-69. PubMed ID: 6866746
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and partial characterization of a murine mammary tumor-associated antigen.
    Chattopadhyay J; Chatterjee R; Chattopadhyay U; Chowdhury JR
    Gan; 1984 Apr; 75(4):334-41. PubMed ID: 6329884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral Anti-Ehrlich carcinoma factor found in mice with tumor resistance acquired by intradermal lipopolysaccharide administration.
    Yamazaki M; Ohkuma S; Mizuno D
    Gan; 1974 Aug; 65(4):337-44. PubMed ID: 4609824
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of ascitic fluid on the growth of Ehrlich tumor and Lewis carcinoma].
    Donenko FV; Kabieva AO; Moroz LV
    Biull Eksp Biol Med; 1992 Jul; 114(8):191-3. PubMed ID: 1467491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of alien H-2 and non-H-2 antigens on a murine mammary tumor cell line, MM46.
    Oshima H; Ishikawa S; Irie R; Tachibana T
    Tohoku J Exp Med; 1987 May; 152(1):67-80. PubMed ID: 3617061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restricted activity of serum blocking factors related to a common tumour antigen in mice.
    Yong WK; Halliday WJ
    Oncology; 1983; 40(3):232-7. PubMed ID: 6843950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.